Aion Therapeutic Inc (TSE:AION) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aion Therapeutic Inc. has issued a bi-weekly update on its management cease trade order, stating it is still in the process of completing its annual and interim financial statements due to complications from a recent acquisition. The company has been granted an extension until October 28, 2024, by the British Columbia Securities Commission and confirms no other material changes or insolvency proceedings are affecting its status.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.